90805-3
Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
Active
Term Description
Vedolizumab trough levels are measured immediately before the next scheduled dose.
Part Descriptions
LP20176-1 trough
In medicine, a trough level is the lowest level that a medicine is present in the body. In a medicine that is administered periodically, the trough level should be measured just before the administration of the next dose in order to avoid overdosing. It should be contrasted with a "peak level", which is the highest level of the medicine in the body, and the "average level", which is the mean level over time. It helps in therapeutic drug monitoring. It is widely used in clinical trials for newer medicines for its therapeutic effectiveness and safety.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia
, Trough levels for therapeutic drug monitoring
LP250843-2 Vedolizumab
Vedolizumab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD) including the subtypes Ulcerative colitis and Crohn's disease. IBD involves inflammation of the intestinal mucosa by leukocytes that cause a disruption in its barrier function. The leukocytes involved are T-cells that express α4β7 integrins which are the target for the drug vedolizumab. Vedolizumab prevents α4β7 integrin from binding with the endothelial surface and T-cells from penetrating the intestinal mucosa. Vedolizumab has proven to be a safe and effective treatment for IBD based in clinical research. Clinical studies have shown that vedolizumab helps achieve corticosteroid-free clinical remission. PMID: 27003961
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Vedolizumab^trough
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
- LC/MS/MS
Additional Names
- Long Common Name
- Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
- Short Name
- Vedolizumab Trough SerPl LC/MS/MS-mCnc
- Display Name
- Vedolizumab trough LC/MS/MS [Mass/Vol]
- Consumer Name Alpha Get Info
- Vedolizumab trough, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.65
- Last Updated
- Version 2.65 (ADD)
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
90794-9 | Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Βεδολιζουμάμπη^ελάχιστα επίπεδα: Synonyms: MCnc Βεδολιζουμάμπη |
es-ES | Spanish (Spain) | Vedolizumab^Valle monitorización terapéutica de fármacos: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Vedolizumab ^ a través: |
fr-FR | French (France) | Védolizumab taux résiduel: |
it-IT | Italian (Italy) | Vedolizumab^valore minimo: Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma valore minimo TDM |
zh-CN | Chinese (China) | 维多珠单抗^波谷: Synonyms: Tandem Mass Spectrometry; |
Example Units
Unit | Source |
---|---|
ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=90805-3
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://